InvestorsHub Logo
Followers 29
Posts 2189
Boards Moderated 1
Alias Born 05/09/2013

Re: TREND1 post# 23665

Saturday, 05/27/2017 8:04:28 AM

Saturday, May 27, 2017 8:04:28 AM

Post# of 32013
With 90 new sales reps how many patients on free samples? How many thru VDEX and One Drop on free samples over the next few months? How many get free refills on samples as well? I've seen doctors do this many times for the first couple of rounds? September will be a good barometer and by then UAE will have kicked in, One Drop thru AMZN, VDEX finally fully up and running and of course our sales force in high gear.

Obviously scripts showed no improvement last week, but stock jumped from $1.13 to $1.68 and closed at $1.52. Almost a 50% move, so something else is clearly underway and once again that move was on very high volume. Furthermore, shorts increased their position over the last few weeks, yet the stock has continued to climb on big volume. Shorts are failing right now in their efforts to suppress the share price.

Good article on disruptive technology in the biotech/medical technology sector and surely explains the hurdles MNKD has faced. It also tells me its not about people not liking Afrezza or that the product doesn't work its just very difficult to change the game in this sector. BP owns us and its a big challenge to get anything thru the process that disrupts the powers stranglehold.

https://www.inc.com/magazine/201706/thomas-goetz/healthcare-disruption-never-happened.html?utm_content=buffer5d8fa&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News